Page last updated: 2024-10-16

gamma-aminobutyric acid and Xerostomia

gamma-aminobutyric acid has been researched along with Xerostomia in 4 studies

gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.

Xerostomia: Decreased salivary flow.

Research Excerpts

ExcerptRelevanceReference
"Gabapentin was shown to be equally efficacious but was better tolerated compared to nortriptyline and can be considered a suitable alternative for the treatment of PHN."6.72Gabapentin versus nortriptyline in post-herpetic neuralgia patients: a randomized, double-blind clinical trial--the GONIP Trial. ( Chandra, K; Gupta, S; Malhotra, S; Pandhi, P; Shafiq, N, 2006)
"Gabapentin was shown to be equally efficacious but was better tolerated compared to nortriptyline and can be considered a suitable alternative for the treatment of PHN."2.72Gabapentin versus nortriptyline in post-herpetic neuralgia patients: a randomized, double-blind clinical trial--the GONIP Trial. ( Chandra, K; Gupta, S; Malhotra, S; Pandhi, P; Shafiq, N, 2006)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gerlinger, I1
Rotzoll, N1
Dunkel, A1
Hofmann, T1
Rickels, K1
Pollack, MH1
Feltner, DE1
Lydiard, RB1
Zimbroff, DL1
Bielski, RJ1
Tobias, K1
Brock, JD1
Zornberg, GL1
Pande, AC1
Chandra, K1
Shafiq, N1
Pandhi, P1
Gupta, S1
Malhotra, S1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Prospective, Cross Over Gabapentin vs Amitriptyline Study on Patients Suffering From Masticatory Muscle Pain[NCT02339662]Phase 450 participants (Anticipated)Interventional2015-02-28Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for gamma-aminobutyric acid and Xerostomia

ArticleYear
[Burning sensation in oral cavity--burning mouth syndrome in everyday medical practice].
    Ideggyogyaszati szemle, 2012, Sep-30, Volume: 65, Issue:9-10

    Topics: Acetamides; Amines; Anti-Anxiety Agents; Antidepressive Agents; Antioxidants; Burning Mouth Syndrome

2012

Trials

2 trials available for gamma-aminobutyric acid and Xerostomia

ArticleYear
Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
    Archives of general psychiatry, 2005, Volume: 62, Issue:9

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anticonvulsants; Anxiety Disorders; Dizziness; Double-Blind

2005
Gabapentin versus nortriptyline in post-herpetic neuralgia patients: a randomized, double-blind clinical trial--the GONIP Trial.
    International journal of clinical pharmacology and therapeutics, 2006, Volume: 44, Issue:8

    Topics: Aged; Amines; Analgesics; Capsules; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; D

2006

Other Studies

1 other study available for gamma-aminobutyric acid and Xerostomia

ArticleYear
Activity-guided identification of (S)-malic acid 1-O-D-glucopyranoside (morelid) and gamma-aminobutyric acid as contributors to umami taste and mouth-drying oral sensation of morel mushrooms (Morchella deliciosa Fr.).
    Journal of agricultural and food chemistry, 2005, May-18, Volume: 53, Issue:10

    Topics: Ascomycota; Chromatography, High Pressure Liquid; gamma-Aminobutyric Acid; Humans; Magnetic Resonanc

2005